Achieving a Future Vision at the 2008 Parenteral Drug Association and the Food and Drug Administration Joint Regulatory Conference, 49685 [E8-19491]
Download as PDF
<![CDATA[
49685
Federal Register / Vol. 73, No. 164 / Friday, August 22, 2008 / Notices
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
IV. Electronic Access
Persons with access to the Internet
may obtain the document at either
https://www.fda.gov/cder/guidance/
index.htm or https://
www.regulations.gov.
Dated: August 13, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–19490 Filed 8–21–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: August 18, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–19491 Filed 8–21–08; 8:45 am]
Food and Drug Administration
[Docket No. FDA–2008–N–0447]
BILLING CODE 4160–01–S
Achieving a Future Vision at the 2008
Parenteral Drug Association and the
Food and Drug Administration Joint
Regulatory Conference
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration,
HHS.
ACTION:
Date and Time: The meeting will be
held on September 8 through 12, 2008,
7 a.m. to 6.
Location: The meeting will be held at
Renaissance Hotel, 999 9th St., NW.,
Washington, DC 20001.
Contact: Wanda Neal-Ballard,
Parenteral Drug Association, PDA
Global Headquarters, Bethesda Towers,
4350 East West Hwy., Suite 200,
Bethesda, MD 20814 or by telephone on
301–986–0293, ext. 111.
Registration and Meeting Information:
See PDA Web site, www.pda.org/
pdafda2008 or contact Wanda NealBallard on 301–986–0293, ext. 111.
From now until August 25, 2008,
registration fees are as follows:
$1,600.00 for Members, $2,000.00 for
Non-members, $615.00 for Government/
Health Authority/Academic and
$230.00 for Students. After August 25,
2008, registration fees are as follows:
$1,800.00 for Members, $2,200.00 for
Non-members, $700.00 for Government/
Health Authority/Academic and
$260.00 for Students.
If you need special accommodations
due to a disability, please contact
Wanda Neal-Ballard at least 7 days in
advance.
Notice of meeting.
The Food and Drug Administration
(FDA) is announcing the following
meeting: Achieving a Future Vision at
the 2008 Parenteral Drug Association
and the Food and Drug Administration
Joint Regulatory Conference. The topics
to be discussed are: FDA’s
Pharmaceutical Inspectorate and the
Global Harmonization Task Force; Trans
Atlantic initiative; Product
development; and legacy products;
Supply chain; Combination products;
and Recall root causes.
National Institutes of Health
Proposed Collection; Comment
Request; California Health Interview
Survey Cancer Control Module (CHIS–
CCM) 2009 (NCI)
SUMMARY: In compliance with the
requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI), the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: California
Health Interview Survey Cancer Control
Module (CHIS–CCM) 2009. Type of
Information Collection Request: New.
Need and Use of Information Collection:
The NCI has sponsored four Cancer
Control Modules in the California
Health Interview Survey (CHIS), and
will be sponsoring a fifth to be
administered in 2009. CHIS is a
telephone survey that collects
population-based, standardized healthrelated data to assess California’s
progress in meeting Healthy People
2010 objectives for the nation and the
state. The CHIS sample is designed to
provide statistically reliable estimates
statewide, for California counties, and
for California’s ethnically and racially
diverse population. Initiated by the
UCLA Center for Health Policy
Research, the California Department of
Health Services, and the California
Public Health Institute, the survey is
funded by a number of public and
private sources. It was first administered
in 2001 to 55,428 adults and
subsequently in 2003 to 42,043 adults,
in 2005 to 43,020 adults, and in 2007 to
48,150 adults. These adults are a
representative sample of California’s
non-institutionalized population living
in households. CHIS 2009, the fifth biannual survey, is planned for
administration to 55,000 adult
Californians. This study will allow NCI
to examine patterns and trends in
cancer screening and follow-up, as well
as to study other cancer-related topics
such as tobacco control, diet, physical
activity, and obesity. Additionally, CHIS
is designed to be comparable to the
National Health Interview Survey
(NHIS) data in order to conduct
comparative analyses. CHIS provides
enhanced estimates for cancer risk
factors and screening among racial/
ethnic minority populations. Frequency
of Response: Once. Affected public:
Individuals or households. Types of
Respondents: U.S. adults and
adolescents (persons 12 years of age and
older). The total annual burden hours
requested are 3,276.94 (see Table A).
The annualized cost to respondents is
estimated at: $55,071.88. There are no
Capital Costs, Operating Costs, and/or
Maintenance Costs to report.
jlentini on PROD1PC65 with NOTICES
TABLE A—ANNUALIZED BURDEN ESTIMATES FOR CHIS 2009
Number of
respondents
Type of respondent
Form type
Adults ........................................................
..............................................................
Adult Pilot .................................................
Adult Survey .............................................
VerDate Aug<31>2005
17:12 Aug 21, 2008
Jkt 214001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Frequency
of response
75
24,000.00
1
1
E:\FR\FM\22AUN1.SGM
22AUN1
Average
time per
response
(hours)
8/60
8/60
Annual hour
burden
10.00
3,200.00
]]>Agencies
[Federal Register Volume 73, Number 164 (Friday, August 22, 2008)]
[Notices]
[Page 49685]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-19491]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-N-0447]
Achieving a Future Vision at the 2008 Parenteral Drug Association
and the Food and Drug Administration Joint Regulatory Conference
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing the following
meeting: Achieving a Future Vision at the 2008 Parenteral Drug
Association and the Food and Drug Administration Joint Regulatory
Conference. The topics to be discussed are: FDA's Pharmaceutical
Inspectorate and the Global Harmonization Task Force; Trans Atlantic
initiative; Product development; and legacy products; Supply chain;
Combination products; and Recall root causes.
Date and Time: The meeting will be held on September 8 through 12,
2008, 7 a.m. to 6.
Location: The meeting will be held at Renaissance Hotel, 999 9th
St., NW., Washington, DC 20001.
Contact: Wanda Neal-Ballard, Parenteral Drug Association, PDA
Global Headquarters, Bethesda Towers, 4350 East West Hwy., Suite 200,
Bethesda, MD 20814 or by telephone on 301-986-0293, ext. 111.
Registration and Meeting Information: See PDA Web site,
www.pda.org/pdafda2008 or contact Wanda Neal-Ballard on 301-986-0293,
ext. 111. From now until August 25, 2008, registration fees are as
follows: $1,600.00 for Members, $2,000.00 for Non-members, $615.00 for
Government/Health Authority/Academic and $230.00 for Students. After
August 25, 2008, registration fees are as follows: $1,800.00 for
Members, $2,200.00 for Non-members, $700.00 for Government/Health
Authority/Academic and $260.00 for Students.
If you need special accommodations due to a disability, please
contact Wanda Neal-Ballard at least 7 days in advance.
Dated: August 18, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-19491 Filed 8-21-08; 8:45 am]
BILLING CODE 4160-01-S
